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A B S T R A C T
Paralleling the global epidemic of obesity ﬁgures in the general population, the incidence of maternal
obesity (BMI >30 kg/m2 at the start of pregnancy) has been rising over the last world. While most
European countries do not systematically report obesity ﬁgures in their pregnant population, the
prevalence of maternal obesity varies from 7 to 25% and seems strongly related to social and educational
inequalities.
Obesity during pregnancy represents an important preventable risk factor for adverse pregnancy
outcomes and is associated with negative long-term health outcomes for both mothers and offspring.
These effects are often aggravated by the high incidence of abnormal glucose tolerance and excessive
gestational weight gain found in this group. The main controversies around the management of
the obese pregnant women are related to (1) the value of repeated weighing during pregnancy, (2) the
optimal gestational weight gain to advise and the lifestyle messages to deliver in order to achieve this, (3)
the optimal strategy and timing of screening for gestational diabetes (GDM) and (4) the optimal timing
and mode of delivery.
These controversies are reviewed in this review, with the exception of screening for gestational
diabetes that is discussed extensively elsewhere in this issue (Benhalima et al.). An agenda for research is
proposed with the hope that it will catch the attention of policy-makers and funders and ultimately lead
to the development of European-wide evidence-based guidelines for clinicians.
 2016 Elsevier Ireland Ltd. All rights reserved.
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Obesity is increasing at an alarming rate worldwide and has
doubled since 1980, with a dramatic increase now also seen in low-
and middle-income countries, particularly in urban settings. In
2014, worldwide 40% of adult women aged 18 years and older were
overweight and 15% were obese. Approximately 42 million
children under the age of 5 were overweight or obese in 2013
[1]. Despite a recent decline in the prevalence of obesity in
preschool-aged children from 2 to 5 year olds in the US (from 13.9%
in 2003–2004 to 8.4% in 2011–2012), obesity among children and
adolescents aged 2–19 years is still too high; with a 17.7% obesity
rate in 6–11 year-olds and a 20.5% obesity rate among 12–19 year-
olds [2]. The high prevalence of maternal and childhood obesity
creates an intergenerational problem with related co-morbidities.
A 2013 National health survey in Belgium (N = 10,829) reported
48% of the general population as either overweight (BMI  25 kg/
m2, 34%) or obese (BMI  30 kg/m2, 14%), with a 3% increase in the
prevalence of obesity since 1997 (11%). Not surprisingly, women of
reproductive age are also affected. The distribution of obesity within
this female population shows that approximately one in three obese
women are between 18 and 44 years of age [3].
Most European countries do not report data on pre-
gestational body mass index (BMI) and gestational weight gain
systematically, so no comprehensive representative picture of
the epidemic burden of maternal obesity is available. Moreover,
information about pre-gestational weight and height is often
based on recalled data or a measurement at the ﬁrst antenatal
visit. Depending on the cohorts studied and the period of
evaluation, the prevalence of obesity in pregnant women ranges
from 1.8% to 25.3% or even up to 40% in American cohorts [4]. A
nationally representative study from 34 maternity units in the
UK (N = 619,323), collecting data from the ﬁrst trimester
maternal BMI between 1989 and 2007, showed a signiﬁcant
increase in ﬁrst trimester maternal obesity over time, which
doubled from 7.6% to 15.6% over 19 years [5].
The Euro-Peristat Network started up in 1999 and aimed to
analyze data about the health and health care of pregnant women
and newborns. They now have ofﬁcial representation from
29 countries across Europe, and have developed a list of
recommended indicators for perinatal health surveillance, based
on a DELPHI consensus process with professionals from EU
member states and Norway. These indicators for perinatal health
are categorized into three sub groups: as core indicators – those
that are essential to monitoring perinatal health – and recom-
mended indicators – those considered desirable for a more
complete picture of perinatal health across the member states
and ﬁnally indicators for further development – those that represent
important aspects of perinatal health but require further work
before they can be implemented within the member states.Please cite this article in press as: Devlieger R, et al. Maternal obesity
Obstet Gynecol (2016), http://dx.doi.org/10.1016/j.ejogrb.2016.04.00Because of a rising incidence of obesity among women, Euro-
Peristat have recently added the monitoring of mother’s pre-
pregnancy BMI, categorized as a recommended perinatal
health indicator. The distribution of pre-pregnancy BMI was
deﬁned for women delivering live or stillborn babies before
pregnancy or at the ﬁrst antenatal visit, and data are based on
existing birth registers in each country [6]. International compar-
isons are often complicated and biased by the heterogeneity of
their regional data registers. Only a few European countries
perform database linkages of maternal, fetal and infant health
determinants systematically and consequently, to improve the
validity and quality of routine data. Lack of optimal linkages
explains the gaps and inconsistencies in the current data
availability [7].
Fig. 1 shows the distribution of maternal obesity in different EU
countries from the Euro-Peristat database. Prevalence of obesity in
countries marked with an asterisk was retrieved from the WHO
database including a general female population aged 20 years or
older.
The variation in the distribution of maternal obesity in the
3 geographical and political different regions of Wallonia, Flanders
and Brussels in Belgium, indicates a socio-demographic and
economic gradient, which needs further exploration. In the region
of Brussels, 66% of neonates are born from a mother with another
ethnicity, indicating the inﬂuence of a complex multi-ethnic
diversity and different levels of welfare [6]. in Europe: where do we stand and how to move forward? Eur J
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Belgium) routinely collected data on maternal pre-pregnancy
weight (kg) and height (m) as well as maternal weight at delivery
(kg) since 2009. Perinatal data from all maternity units (N = 65)
are collated centrally, subjected to an error detection program,
and checked for accuracy and completeness through feedback
with the individual units and reassessment of patient records
when needed [8]. This enables us to make a representative
regional picture of maternal obesity and gestational weight gain
(GWG) in this region. The prevalence of maternal obesity
signiﬁcantly increased from 2009 (10.2%) to 2014 (11.4%). In
the total term population, including only singletons
(N = 337,590), most obese pregnant women (72%) were class I
obese (BMI 30–34.9 kg/m2), whereas 21% were class II obese (BMI
35–39.9 kg/m2) and 7% class III obese (BMI  40 kg/m2). The mean
BMI (kg/m2, SD) signiﬁcantly increased from 23.9 (4.5) in 2009 to
24.2 (4.6) in 2014, with a same plateau since 2012. Concurrently
maternal obesity also has an ethnic and socio-economical
gradient [9], which increases even more the burden of maternal
obesity on public health issues.
Euro-Peristat aims to build up a sustainable and qualitative
perinatal health database. This development is of great value to
have common and comparable data about maternal population
characteristics like pre-gestational BMI.
Maternal obesity and short- and long-term complications for
the mother and her offspring
Obesity (BMI  30 kg/m2) during pregnancy is a major public
health concern because of the increased risks for both the mother
and child. The increased risks for the mother of a miscarriage,
metabolic and cardiovascular dysfunctions presented as gesta-
tional diabetes and hypertension, pre-eclampsia, dysfunctional
labor and cesarean section have been well described [9–
15]. Complications are even higher when maternal obesity is
combined with excessive gestational weight gain, especially the
increased risk of cesarean section, macrosomia and postpartum
weight retention [12]. For the neonate, there is an increased risk of
congenital malformations [16], macrosomia and admission to a
neonatal care unit [9,12,17]; the risk of stillbirth is also strongly
related to maternal BMI [18,19].
In the long term, children of obese mothers who were prone
to metabolic dysfunctions in utero, in utero programming,
will face further metabolic and cardiovascular problems [20,21],
as well as neurocognitive developmental problems [22]. Fur-
thermore, maternal weight retention between the ﬁrst and
second pregnancy, which is often a result of excessive
gestational weight gain and postpartum weight retention
(PPWR), is associated with an increased risk for perinatal
complications in the next pregnancy, even in underweight and
normal weight women [23,24]. Concurrently, failure to lose
pregnancy related weight in an appreciable time of 6 months
after delivery is an important indicator of obesity in midlife, and
is fueling an intergenerational cycle of obesity within the female
population and offspring [21,22].
In developed countries, obesity accounts for 2–7% of the total
healthcare costs [1]. A recent retrospective prevalence-based study
on health service utilization and costs in obese pregnant women up
to 2 months following delivery showed respectively a 23% and 37%
increased mean total cost in overweight and obese women,
compared with normal weight pregnant women, and this was after
adjusting for maternal age, parity, ethnicity and comorbidity
[25]. Moreover, gestational diabetes increases costs of care of
approximately 34% compared to women without gestational
diabetes [26].Please cite this article in press as: Devlieger R, et al. Maternal obesity
Obstet Gynecol (2016), http://dx.doi.org/10.1016/j.ejogrb.2016.04.00Controversies in the management of maternal obesity
The value of routine weighing during pregnancy
In the UK, routine weighing was phased out on recommenda-
tions of the National Institute for Health Care and Excellence (NICE)
as it was potentially resulting in increased maternal stress without
proven beneﬁt [27]. This approach was recently supported by an
Australian RCT in which 782 pregnant women were randomly
assigned to systematic weighing during pregnancy versus routine
care. Routine weighing at antenatal visits did not reduce total
gestational weight gain, neither did it reduce the incidence of
excessive gestational weight gain [28]. Unfortunately, the study
was relatively small and did not report on perceived or measured
stress or anxiety caused by (not) being weighed and discussing
these issues during the antenatal visits.
In contrast to this, weighing in pregnancy still forms a routine
part of antenatal practice in many European countries like France,
Denmark, Germany, Italy and Belgium. Weighing at antenatal
visits has substantial advantages: the recorded weight can initiate
discussions on appropriate weight gain during pregnancy and
about life-style modiﬁcations in order to achieve this. Also, many
women are anxious about their weight during pregnancy. In
women, weight gain can induce anxiety and stress, even when
related to a ‘‘physiologic condition’’ like pregnancy. Adequate
measurements and counseling in these situations could also have a
possible stress-reduction affect.
This idea is supported by a recent RCT comparing usual care
versus regular weighing, setting maximum weight gain targets and
feedback by community midwives in pregnant women, irrespec-
tive of their BMI. The study showed a modest difference favoring
the intervention group in the percentage of women gaining
excessive gestational weight (23.5% versus 29.4%). More interest-
ingly, the intervention group also consistently reported smaller
increases in depression and anxiety scores throughout pregnancy
compared with usual care. Most women commented the
intervention was useful in encouraging them to think about their
weight and believed it should be part of routine antenatal care.
Community midwives felt the intervention could be implemented
within routine care without adding substantially to consultation
length, thus not perceived as adding substantially to their
workload [29].
From a public health perspective, there are many advantages to
routine weighing and recording this in the perinatal databases. In
the region of Flanders, Belgium, where patients are weighed
routinely, BMI and gestational weight gain have been available for
all pregnancies in the region since 2009. This has led to a better
insight in the socio-demographics of gestational weight gain and
maternal obesity, the related perinatal outcomes and the effects of
weight ﬂuctuation between pregnancies [9,23].
The optimal gestational weight gain and strategy for prevention of
obesity related complications
The additive effect of excessive gestational weight gain on the
incidence of obesity-related complications like gestational diabe-
tes, hypertensive disorders and cesarean birth is well established
[12]. Additionally, there is increasing evidence that excessive
gestational weight gain and the subsequent inter-pregnancy
weight retention – which is often a result of retained weight after
delivery – is associated with more complications in future
pregnancy [23,30].
Therefore it seems important to achieve a gestational weight
gain in obese pregnant women that is associated with the best
outcome. Recommendations for healthy weight gain in pregnancy
related to the BMI at the start of pregnancy were published by the in Europe: where do we stand and how to move forward? Eur J
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[31]. Ideally, obese women should gain between 5 and 9 kg during
pregnancy. Some have suggested that these recommendations are
not strict enough and that a lower gain would lead to better
outcomes, especially in obesity class II (BMI 35–40) and III
(BMI > 40) [32,33]. Still about half of the overweight or obese
pregnant women have gestational weight gain in excess of these
recommendations. Therefore a large number of trials have
conducted clinical programs to reduce gestational weight gain
by promoting healthy eating, physical activity or a combination of
those. While some trials were successful in reducing gestational
weight gain [34,35] or improving behavior [36], this impacted very
little on relevant maternal and neonatal outcomes in meta-
analyses [37,38]. The ideal weight management in obese pregnant
women therefore remains to be determined.
The optimal strategy for screening for gestational diabetes GDM
This topic has been addressed at length by Benhalima et al. in
the same issue.
The optimal timing and mode of delivery
Labor is often complicated in obese pregnant women, and this
in an apparently contradictory way. On one hand, a high BMI is
associated with an increased risk for induced and spontaneous
preterm birth [39]. On the other hand, obese women have a higher
risk than overweight and lean women to progress beyond term,
with a higher incidence of post-term childbirths especially when
BMI reaches 35 kg/m2 or more [11,40].
Obese women tend to have higher odds for induction of labor
and failure to progress during labor [11,41]. Once labor is
established, obese women are at increased risk of cesarean
delivery, operative vaginal delivery, and failed trial of labor after
cesarean delivery.
Most studies advocate vaginal delivery as the preferred way of
delivery in obese patients. In the absence of macrosomic fetus,
induction of labor is not advised. In the presence of macrosomia, a
recent European multicenter trial showed that early term (37–
38 + 6w) induction of labor for suspected large-for-date fetuses
(estimated fetal weight (EFW) > 95th percentile) is associated
with a reduced risk of shoulder dystocia and associated morbidity
compared with expectant management. In this study, induction of
labor did not increase the risk of cesarean delivery and improved
the likelihood of spontaneous vaginal delivery [42]. This approach
however remains debated and some guidelines advise an elective
cesarean section in cases with suspected macrosomia
(EFW > 4500 g) [43].
Psychological and motivational components
Obesity and anxiety during pregnancy and postpartum
Obesity is increasing among women of reproductive age and
adverse maternal and neonatal outcomes are well described.
Concurrently, several studies have looked at evolutions of
maternal anxiety and depression during pregnancy and the
postpartum period, and they found that antenatal anxiety occurs
frequently and increases the likelihood of antenatal and postnatal
depression [44,45]. Moreover, prospective studies have shown a
link between antenatal maternal anxiety/stress and cognitive,
behavioral, and emotional problems in the child, fueling the
developmental origins of health and diseases’ hypothesis [46,47].
It is generally well known that obese women are more likely to
suffer from higher levels of anxiety and depression, compared toPlease cite this article in press as: Devlieger R, et al. Maternal obesity
Obstet Gynecol (2016), http://dx.doi.org/10.1016/j.ejogrb.2016.04.00normal-weight women, but these associations are less studied in
pregnant women.
Psychological factors including stress and anxiety can also
inﬂuence maternal weight. Pregnant women with elevated levels
of stress and anxiety consume more fats, oils, sweets and snacks,
have decreased intakes of vitamins and are often described as
‘emo-eaters’ [48]. We recently compared levels of anxiety and
depressed mood during pregnancy in obese versus normal-weight
women and found higher levels of anxiety and depressive
symptoms in obese women. Concurrently, lifestyle behavior
(smoking) and socio-demographic characteristics as maternal
education, ethnicity, living with a partner and psychological
history were all related to the weight status of the pregnant
women, making them even more vulnerable [49]. These associa-
tions were also conﬁrmed in other studies [50,51]. Although the
controversies regarding the optimal starting point of initiating
lifestyle coaching in obese women to attain better maternal and
neonatal health outcomes [52], lifestyle coaching in obese
pregnant women can increase the psychological wellbeing, with
beneﬁcial effects on healthy gestational weight gain [35]. Besides,
positive associations are shown between psychological factors
during pregnancy, deﬁned as levels of anxiety and feelings of
depression, and weight retention at 6 and 18 months after delivery
[53,54]. In the light of the in utero programming theory, the effect
of the mental health of obese pregnant women should be explored
further and its ﬁndings should be taken into account during the
development of perinatal care programs for pregnancy in high risk
groups.
Obesity and motivational coaching
Obese pregnant women often lack knowledge about the impact
of obesity during pregnancy; and communication with healthcare
providers is often experienced as stressful, confusing and
judgmental [55], and thus maternal expectations are often not
met [56–58]. Most qualitative research concludes that improved
training in communication skills with a less judgmental behavior
and more sensitive interactions between healthcare providers and
obese women is needed [59].
Motivational interviewing technique can be a supportive tool in
the communication about health promotion and have showed
promising effects in reducing weight in a non-pregnant population
[60,61]. Motivational interviewing is based on a directive method
of communication with a focus on intrinsic motivation. Motiva-
tional issues focus on developing discrepancy and exploring and
resolving ambivalence about making changes, without undue
pressure. Women are asked to identify behaviors that need to
change and set small stepwise goals from their own intention to
achieve a healthy behavior. Personal barriers to behavioral change
are explored and as much as possible positive verbal reinforcement
is given to increase each pregnant woman’s self-conﬁdence and
self-efﬁcacy [62].
Topics for future research
Suggested topics for future collaboration and research concerning
maternal obesity in Europe
 Standardization of registration of BMI and GWG in perinatal
databases throughout Europe and related core outcome param-
eters.
 Prospective controlled studies on safety of gestational weight
gain below recommendations in obesity class I, II and III.
 Identiﬁcation of socio-demographic determinants of obese
reproductive women by geographical region to target educational in Europe: where do we stand and how to move forward? Eur J
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gestational BMI.
 Evaluation whether an altered onset and progression of labor in
obese pregnant women calls for customized labor timeframes
and targeted dosages of oxytocin.
 Determination of pre-conceptional needs of overweight and
obese women and effects of speciﬁc and targeted lifestyle
interventions to increase the likelihood of a successful pregnancy
and healthy infant.
 Determination of the optimal screening strategy to diagnose and
treat GDM in obese pregnant women to prevent short and long-
term risks related to GDM in mother and offspring (cfr Benhalima
et al. further in this issue).
 Studies on adequate folic acid and vitamin D dosages to prevent
neural tube defects and GDM respectively in obese pregnant
women.
 Studies on the effectiveness of pre-conception health programs
and interventions for improving pregnancy outcomes in
overweight and obese women.
 Deﬁnition of modiﬁed regular physical activity exercises for
obese pregnant women to maintain physical ﬁtness, manage
weight, improve psychological well-being and reduce risk for
GDM.
 Description of an optimal strategy for lifestyle interventions
during pregnancy, including mobile health applications to
improve relevant composite maternal and neonatal outcomes.
 Studies on the impact of maternal diet in obese pregnant women
and mothers on the volume and quality of breastmilk.
 Determination of the inﬂuence of a vulnerable socio-economic
gradient in obese reproductive women on adverse maternal and
neonatal outcomes.
 Determination of the inﬂuence of maternal pre-conceptional and
prenatal environment on epigenetic modiﬁcations in the
neonate.
 Studies on the long-term effects of obesity surgery before
pregnancy on maternal and offspring health.
Conclusion
An integrated approach for the management of obesity in
women of reproductive age who are planning a pregnancy is
crucial. Management should begin before conception and continue
through pregnancy and the postpartum period within a multidis-
ciplinary team focusing on mental wellbeing, healthy eating and
physical activity including weight management techniques.
Maternal obesity not only implies a personal responsibility but
also infers a social environmental, political and economic
responsibility. Cost-effectiveness of regulatory frameworks in-
creasing the accessibility and availability of healthy food and
drinks must be balanced against the burden of reduced quality of
maternal health and related costs regarding all the co-morbidities
in the mother as well as in the offspring.
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